Telix Pharmaceuticals Ltd (TLX) SEC Filings & Financial Intelligence
Telix Pharmaceuticals Ltd (TLX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TLX
CIK: 2007191
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: C3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerBradley Peake
Audit LocationMelbourne, Australia
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001628280-26-063875 | View SEC Doc Filr Page |
| 6-K | 2026-09-21 | 2026-09-21 | 6-K | 0001628280-26-062813 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-07 | FORM 4 | 0001628280-26-061944 | View SEC Doc Filr Page |
| 6-K | 2026-09-14 | 2026-09-14 | 6-K | 0001628280-26-061892 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | 6-K | 0001628280-26-059952 | View SEC Doc Filr Page |
| 6-K | 2026-09-01 | 2026-09-01 | 6-K | 0001628280-26-059684 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-06-30 | 6-K | 0001628280-26-058126 | View SEC Doc Filr Page |
| 6-K | 2026-07-21 | 2026-06-30 | 6-K | 0001628280-26-048922 | View SEC Doc Filr Page |
| 6-K | 2026-07-02 | 2026-07-01 | 6-K | 0001628280-26-046936 | View SEC Doc Filr Page |
| 6-K | 2026-05-21 | 2025-05-20 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000027 | View SEC Doc Filr Page |
| 3 | 2026-05-18 | 2026-05-11 | FORM 3 | 0001628280-26-036099 | View SEC Doc Filr Page |
| 3 | 2026-05-18 | 2026-05-11 | FORM 3 | 0001628280-26-036098 | View SEC Doc Filr Page |
| 3 | 2026-05-18 | 2026-05-11 | FORM 3 | 0001628280-26-036096 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-04-28 | FORM 4 | 0001628280-26-031608 | View SEC Doc Filr Page |
| 6-K | 2026-04-23 | 2026-04-22 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000024 | View SEC Doc Filr Page |
| 6-K | 2026-04-21 | 2026-04-20 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000021 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-19 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000019 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | 6-K | 0001140361-26-014540 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | 6-K | 0001140361-26-014495 | View SEC Doc Filr Page |
| 6-K | 2026-04-13 | 2026-04-12 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000017 | View SEC Doc Filr Page |
| 6-K | 2026-04-10 | 2026-04-09 | 6-K | 0001628280-26-024572 | View SEC Doc Filr Page |
| 6-K | 2026-04-09 | 2026-04-09 | 6-K | 0001628280-26-024320 | View SEC Doc Filr Page |
| 6-K | 2026-04-07 | 2026-03-31 | 6-K | 0001628280-26-023982 | View SEC Doc Filr Page |
| 6-K | 2026-04-02 | 2026-04-01 | CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS | 0002007191-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-04-01 | 2026-03-29 | FORM 4 | 0001628280-26-022909 | View SEC Doc Filr Page |